PHF1 and Alzheimer disease: We found that GA decreased PHF1 immunopositivity in the CA1 region of the hippocampus of 3xTg AD mice following 4 weeks (Supplementary Figure 1) and 8 weeks of treatment (Figures 3A,B; P = 0.04).